Pharma — Marts 2026
-
Test
-
Lundbecks topchef, Charl Van Zyl, kritiserer Europas bureaukratiske system og manglende incitamenter for innovation, som hæmmer medicinalindustriens vækst. I interviewet med Finans fremhæver Van Zyl derudover, at selskabet fremover vil fokusere på USA og Kina, hvor rammerne for investeringer og innovation er stærkere, mens Europa risikerer at tabe terræn.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind